FDA
approval
· 2023-09-21
FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., authorizing a supplemental action related to a generic Montelukast…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MONTELUKAST (MONTELUKAST)